NA Selank Amidate

NA Selank Amidate

NA Selank Amidate

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

 

SKU: 198884 Flokkur:
Deildu ást þinni

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal asetýleringu and C-terminal amidation based on the original structure of Selank.

This results in an increased half-life, endurbætt blóð-heila hindrun penetration efficiency, and prolonged bioactivity in both molecular and animal models.

Þar að auki, NA Selank Amidate exhibits potent immunomodulation and anti-stress activity.

Röð

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS númer

/

Sameindaformúla

C35H60N12O9

Mólþyngd

792.94

Research Of NA Selank Amidate

1.Retained and Enhanced Efficacy

Efficacy-wise,NA Selank Amidate retains all of the characteristics of Selank, eftirlit gamma-aminobutyric acid (GABA) neurotransmission in the brain while also modulating the dópamínvirkt og serótónvirkt systems to deliver outstanding kvíðastillandi og antidepressant effects.

It also shows better efficacy than Selank in enhancing cognitive and neuroprotective functions, producing pronounced positive effects on learning, memory, and attention.

2.Anxiolytic and Mood-Stabilizing Effects

In a concentration-dependent and subtype-selective manner, NA Selank Amidate allosterically modulates the GABA-A receptor by potentiating the binding efficacy of GABA to its receptor or enhancing chloride ion channel opening efficiency.

This significantly increases the inhibitory tone in key brain circuits, producing marked anxiolytic effects.

Ennfremur, the side effects of this anxiolytic action are significantly milder than those of conventional anxiolytic drugs, making NA Selank Amidate a more attractive mood-stabilizing compound.

3.Cognitive Enhancement and Neuroprotection

NA Selank Amidate directly activates BDNF gene transcription by inducing fosfórun of the promoter-located CREB transcription factor and acetylation of histone H3, increasing BDNF mRNA levels 3.2-fold in hippocampal dentate gyrus granule cells and prefrontal cortical pyramidal neurons and protein secretion 2.8-fold within 24 klukkustundir.

This activates the TrkB receptor signaling pathway downstream, inducing the Ras-MAPK and PI3K-Akt cascade to increase dendritic hrygg density by 39%, upregulate synaptophysin expression by 45%, and restore LTP amplitude to baseline.

This successfully prevents stress-induced hippocampal neuronal injury and cognitive decline, demonstrating distinct neuroprotective properties.

4.Immunomodulatory and Anti-Stress Effects

NA Selank Amidate is a competitive inhibitor of enkephalin-degrading enzyme, protecting endogenous opioid peptides frá vatnsrof and thereby elevating their levels, while it inhibits LPS (lipopolysaccharide)-induced expression of pro-inflammatory cýtókín þar á meðal IL-6 og TNF-α by 40–60% in astrocytes.

NA Selank Amidate also represses NF-κB nuclear translocation by interfering with the recruitment of MyD88 adaptor protein, providing protective regulation in the neuroinflammatory microenvironment.

COA

HPLC

MS

(1) Við viljum, C. R.; Hvítur, C. M. Róandi-svefnlyf sem hafa áhrif á gamma-amínósmjörsýruviðtaka: Einbeittu þér að Flunitrazepam, Gamma-hýdroxýsmjörsýra, Phenibut, og Selank. J Clin Pharmacol 2021, 61 Suppl 2, S114-S128. DOI: 10.1002/jcph.1922 From NLM M

(2) Greyið, A.; Kolomin, T.; Andreeva, L.; Bondarenko, E.; Myasoedov, N.; Slominsky, P.; Shadrina, M. Peptíð Selank eykur áhrif díazepams til að draga úr kvíða í ófyrirsjáanlegum langvarandi vægri streitu hjá rottum. Hegðu þig Neurol 2017, 2017, 50910

(3) Pinna, L. G.; Nadorova, A. V.; Antipova, T. A.; Kruglov, S. V.; Kudrin, V. S.; Durnev, A. D. Selank, Peptíð hliðstæða Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex

(4) Pinna, L. G.; Nadorova, A. V.; Seredenín, S. B. Selank hindrar etanól-framkallaða ofhreyfingu og birtingu hegðunarnæmis í DBA/2 músum. Bull Exp Biol Med 2016, 162 (1), 56-59. DOI: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) Kostnaður, N. V.; Sokolov, O.; Gabaeva, M. V.; Grívennikov, ég. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [Semax og selank hamla enkefalín niðurbrotsensím úr sermi manna]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:10113730028

(6) Ég veit það ekki, G. G.; Teleshova, E. S.; Bochkarev, V. K.; Koschelev, V. V.; Syunyakov, T. S. P.3.036 Skáldsaga kvíðastillandi Selank: Niðurstöður II. stigs klínískra rannsókna. Evrópsk taugasállyfjafræði 2005, 15, S159-S160. DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, P. A.; Shadrina, M. ég.; Kolomin, T. A.; Stavrovskaya, A. V.; Filatova, E. V.; Andreeva, L. A.; Illarioshkin, S. N.; Myasoedov, N. F. Peptíð semax og selank hafa áhrif á hegðun rotta með 6-OHDA framkallað PD-lík parkinsonism. Dokl Biol Sc

(8) Sollertinskaja, T. N.; Shorokhov, M. V.; Myasoedov, N. F. Heilaverndandi áhrif Semax og Selank hjá prímötum við mismunandi tegundir taugaveiki. International Journal of Psychophysiology 2008, 69 (3). DOI: 10.1016/j.ijpsycho.2008.05.356.

Röð:

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS:

/

M.W:

792.94 g/mól

Heim Leita Whatsapp Þjónusta Vara